T
TOBAM Portfolio holdings
AUM
$256M
This Quarter Return
-7.74%
1 Year Return
+13.59%
3 Year Return
+36.98%
5 Year Return
+80%
10 Year Return
+220.89%
AUM
$1.6B
AUM Growth
+$1.6B
(-20%)
Cap. Flow
-$226M
Cap. Flow
% of AUM
-14.18%
Top 10 Holdings %
Top 10 Hldgs %
25.61%
Holding
503
New
74
Increased
179
Reduced
100
Closed
74
Top Buys
| 1 |
Quest Diagnostics
DGX
|
$23.9M |
| 2 |
Church & Dwight Co
CHD
|
$19.2M |
| 3 |
Kimberly-Clark
KMB
|
$17.9M |
| 4 |
Eversource Energy
ES
|
$17.3M |
| 5 |
Expedia Group
EXPE
|
$11.8M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$31.2M |
| 2 |
Conagra Brands
CAG
|
$27.1M |
| 3 |
Eli Lilly
LLY
|
$23.9M |
| 4 |
Sealed Air
SEE
|
$20.8M |
| 5 |
General Mills
GIS
|
$18.4M |
Sector Composition
| 1 | Healthcare | 28% |
| 2 | Consumer Staples | 25.89% |
| 3 | Communication Services | 10.3% |
| 4 | Technology | 7.09% |
| 5 | Materials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pfizer
PFE
$141B
| $46.4M | 2.91% |
885,098
-149,451
| -14% | -$7.84M |
|
|
2
General Mills
GIS
$26.4B
| $44.9M | 2.81% |
594,592
-243,263
| -29% | -$18.4M |
|
|
3
Kimberly-Clark
KMB
$42.8B
| $43.7M | 2.74% |
323,296
+132,681
| +70% | +$17.9M |
|
4
Merck
MRK
$210B
| $43.6M | 2.73% |
477,807
+119,071
| +33% | +$10.9M |
|
5
Kellanova
K
$27.6B
| $40.7M | 2.55% |
570,252
-157,517
| -22% | -$11.2M |
|
6
Clorox
CLX
$14.5B
| $40.7M | 2.55% |
288,398
-50,947
| -15% | -$7.18M |
|
7
Becton Dickinson
BDX
$55.3B
| $37.8M | 2.37% |
153,221
-7,370
| -5% | -$1.82M |
|
8
Hormel Foods
HRL
$14B
| $37.7M | 2.36% |
796,098
-84,912
| -10% | -$4.02M |
|
9
J.M. Smucker
SJM
$11.8B
| $37.1M | 2.32% |
289,743
-41,656
| -13% | -$5.33M |
|
10
Electronic Arts
EA
$43B
| $36.3M | 2.27% |
298,330
+96,482
| +48% | +$11.7M |
|
11
Gen Digital
GEN
$18.6B
| $36.2M | 2.27% |
1,650,117
+46,097
| +3% | +$1.01M |
|
|
12
Church & Dwight Co
CHD
$22.7B
| $35.9M | 2.25% |
387,276
+207,082
| +115% | +$19.2M |
|
|
13
Eli Lilly
LLY
$657B
| $35.9M | 2.25% |
110,650
-73,636
| -40% | -$23.9M |
|
14
C.H. Robinson
CHRW
$15.2B
| $35.9M | 2.25% |
353,763
+75,367
| +27% | +$7.64M |
|
|
15
Quest Diagnostics
DGX
$20.3B
| $34.5M | 2.16% |
259,352
+179,847
| +226% | +$23.9M |
|
16
Biogen
BIIB
$19.4B
| $33M | 2.07% |
161,853
-15,840
| -9% | -$3.23M |
|
17
Campbell Soup
CPB
$9.52B
| $33M | 2.07% |
686,574
-198,320
| -22% | -$9.53M |
|
18
Newmont
NEM
$81.7B
| $30.7M | 1.93% |
515,246
+70,468
| +16% | +$4.2M |
|
19
Neurocrine Biosciences
NBIX
$13.8B
| $29.9M | 1.87% |
306,494
+90,037
| +42% | +$8.78M |
|
20
Consolidated Edison
ED
$35.4B
| $28.2M | 1.77% |
296,158
-51,414
| -15% | -$4.89M |
|
21
Dollar Tree
DLTR
$22.8B
| $27.7M | 1.73% |
177,463
-103,667
| -37% | -$16.2M |
|
22
Alnylam Pharmaceuticals
ALNY
$58.5B
| $26.3M | 1.65% |
180,101
+24,516
| +16% | +$3.58M |
|
23
Franco-Nevada
FNV
$36.3B
| $22.2M | 1.39% |
169,313
-47,172
| -22% | -$6.19M |
|
24
Assurant
AIZ
$10.9B
| $21.3M | 1.33% |
123,020
-50,886
| -29% | -$8.8M |
|
25
Moderna
MRNA
$9.37B
| $21M | 1.31% |
146,771
-7,406
| -5% | -$1.06M |
|